Sudden sensorineural hearing loss-A contemporary review of management issues  

作　　者：Anup Singh David Victor Kumar Irugu 

机构地区：[1]Department of Otorhinolaryngology and Head and Neck Surgery,Medanta-the Medicity,Gurugram,Haryana,India [2]Department of Otorhinolaryngology and Head and Neck Surgery,All India Institute of Medical Sciences,New Delhi,India

出　　处：《Journal of Otology》2020年第2期67-73,共7页中华耳科学杂志（英文版）

摘　　要：Sudden sensorineural hearing loss(SSNHL)is an enigmatic entity,with obscure pathophysiology and debatable efficacy of the treatment agents used.An underlying cause is identified in only 10-15%of cases.The management of the remaining patients,classified as‘idiopathic’,is empirical,and is conventionally with systemic steroids,vasodilator therapy,rheological agents,and antioxidants,to list a few amongst the host of the agents employed for the treatment.The availability of conflicting outcomes and lack of conclusive evidence has resulted in the propagation of consensus-based treatment protocols.In the present review,we discuss the various controversial issues and newer developments in the management of idiopathic SSNHL.The current review aims to present a narrative outlook of the updated evidence base available from PUBMED,augmented with relevant designated publications.

关 键 词：Hearing loss SUDDEN SENSORINEURAL INSTILLATION Drug DEXAMETHASONE Prognosis 

分 类 号：R764.43[医药卫生—耳鼻咽喉科]